Literature DB >> 18973180

Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies.

Stephan Clasen1, Stefan-Martin Krober, Bora Kosan, Hermann Aebert, Falko Fend, Andrea Bomches, Claus D Claussen, Philippe L Pereira.   

Abstract

BACKGROUND: Radiofrequency (RF) ablation is an increasingly applied technique. Promising results of hepatic RF ablation raised expectations of its capabilities for treatment of primary and secondary lung tumors. Because of different thermal and electrical properties of lung tissue, compared with liver tissue, a simple analogy of tissue response is not possible. The authors aimed to evaluate the effectiveness of image-guided pulmonary RF ablation and to characterize pathomorphology of tissue response.
METHODS: RF ablations of 11 pulmonary malignancies in 9 patients were performed under computed tomography (CT)-guidance. Three days after RF ablation, surgical resection was performed followed by pathologic examination. Specimens were evaluated macroscopically, histologically by hematoxylin and eosin (H & E) staining, terminal deoxy-nucleotidyl transferase-mediated nick end-labeling (TUNEL), and electron microscopy.
RESULTS: Tumor tissues and adjacent lung tissues were characterized by double-strand fragmentation as determined by TUNEL. Ultrastructurally apoptotic bodies were found, indicating apoptotic cells. Criteria for tissue necrosis were not fulfilled by standard histological staining (H & E), showing preserved tissue architecture and only few microscopic cellular details suggestive of tumor regression. Because of DNA fragmentation, as determined by TUNEL and results from electron microscopy, the authors confirmed the tumor tissue to be completely ablated in 10 (90.9%) cases. However, in 2 cases, a safety margin was absent.
CONCLUSIONS: CT-guided pulmonary RF ablation of pulmonary malignancies is a locally effective treatment. Three days after RF ablation, tumor tissue seemed to be thermally fixed still showing characteristics of vital tumor tissue in standard histological staining; however the tissue proved to be in regression toward coagulative necrosis verified ultrastructurally and by TUNEL. (c) 2008 American Cancer Society

Entities:  

Mesh:

Year:  2008        PMID: 18973180     DOI: 10.1002/cncr.23882

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation.

Authors:  Sebastian P Haen; Cécile Gouttefangeas; Diethard Schmidt; Andreas Boss; Stephan Clasen; Alexandra von Herbay; Bora Kosan; Hermann Aebert; Philippe L Pereira; Hans-Georg Rammensee
Journal:  Cell Stress Chaperones       Date:  2011-03-26       Impact factor: 3.667

2.  Residual tumor after laser ablation of human non-small-cell lung cancer demonstrated by ex vivo staining: correlation with invasive temperature measurements.

Authors:  Christian Oliver Martin Hoffmann; Christian Rosenberg; Albert Linder; Norbert Hosten
Journal:  MAGMA       Date:  2011-06-09       Impact factor: 2.310

3.  Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation.

Authors:  Lambros Tselikas; Thierry de Baere; Frederic Deschamps; Antoine Hakimé; Benjamin Besse; Christophe Teriitehau; Vincent de Montpreville; Julien Adam
Journal:  Eur Radiol       Date:  2016-06-14       Impact factor: 5.315

Review 4.  Microwave Ablation in Primary Lung Malignancies.

Authors:  Amgad M Moussa; Etay Ziv; Stephen B Solomon; Juan C Camacho
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

5.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.

Authors:  Muneeb Ahmed; Luigi Solbiati; Christopher L Brace; David J Breen; Matthew R Callstrom; J William Charboneau; Min-Hua Chen; Byung Ihn Choi; Thierry de Baère; Gerald D Dodd; Damian E Dupuy; Debra A Gervais; David Gianfelice; Alice R Gillams; Fred T Lee; Edward Leen; Riccardo Lencioni; Peter J Littrup; Tito Livraghi; David S Lu; John P McGahan; Maria Franca Meloni; Boris Nikolic; Philippe L Pereira; Ping Liang; Hyunchul Rhim; Steven C Rose; Riad Salem; Constantinos T Sofocleous; Stephen B Solomon; Michael C Soulen; Masatoshi Tanaka; Thomas J Vogl; Bradford J Wood; S Nahum Goldberg
Journal:  J Vasc Interv Radiol       Date:  2014-10-23       Impact factor: 3.464

6.  Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways.

Authors:  Stephanie A Solazzo; Muneeb Ahmed; Rachel Schor-Bardach; Wei Yang; Geoffrey D Girnun; Syed Rahmanuddin; Tatyana Levchenko; Sabina Signoretti; Douglas R Spitz; Vladimir Torchilin; S Nahum Goldberg
Journal:  Radiology       Date:  2010-02-16       Impact factor: 11.105

7.  Pathologic Diagnosis and Genetic Analysis of Sequential Biopsy Following Coaxial Low-Power Microwave Thermal Coagulation For Pulmonary Ground-Glass Opacity Nodules.

Authors:  Jiachang Chi; Min Ding; Zhi Wang; Hao Hu; Yaoping Shi; Dan Cui; Xiaojing Zhao; Bo Zhai
Journal:  Cardiovasc Intervent Radiol       Date:  2021-04-06       Impact factor: 2.740

8.  A Comparative Study of Ablation Boundary Sharpness After Percutaneous Radiofrequency, Cryo-, Microwave, and Irreversible Electroporation Ablation in Normal Swine Liver and Kidneys.

Authors:  Francois H Cornelis; Jeremy C Durack; Simon Y Kimm; Thomas Wimmer; Jonathan A Coleman; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  Cardiovasc Intervent Radiol       Date:  2017-05-17       Impact factor: 2.740

9.  Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer.

Authors:  T Schneider; A Sevko; C P Heussel; L Umansky; P Beckhove; H Dienemann; S Safi; J Utikal; H Hoffmann; V Umansky
Journal:  Clin Exp Immunol       Date:  2015-04-15       Impact factor: 4.330

Review 10.  Modern diagnostic and therapeutic interventional radiology in lung cancer.

Authors:  Wai-Kit Lee; Eddie W F Lau; Kwang Chin; Oliver Sedlaczek; Karin Steinke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.